HOXA5 and ovarian carcinoma: According to Oncomine (http://www.oncomine.org)16, HOXA5 is highly expressed in AML, gastrointestinal stromal tumors, and glioblastomas, whereas it is weakly expressed in breast, colon, lung, and ovarian cancers.